dc.contributor.author |
Nugraha, Edwin Setiawan |
|
dc.date.accessioned |
2017-03-30T00:33:11Z |
|
dc.date.available |
2017-03-30T00:33:11Z |
|
dc.date.issued |
2010-08 |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/5078 |
|
dc.description.abstract |
Immunotherapy is a relatively new cancer treatment currently being investigated
intensively. The goal of the treatment is to strengthen the body's own natural ability
to combat cancer by enhancing the effectiveness of the immune system.
Immunotherapy is divided into three groups: immune response modifier,
monoclonal antibody and cancer vaccines. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Terengganu: Universiti Malaysia Terengganu |
en_US |
dc.relation.ispartofseries |
RC 271.I45 N8 2010; |
|
dc.subject |
RC 271.I45 N8 2010 |
en_US |
dc.subject |
Nugraha, Edwin Setiawan |
en_US |
dc.subject |
Tesis FST 2010 |
en_US |
dc.subject |
Tumors -- Immunological aspects |
en_US |
dc.subject |
Immunotherapy -- Evaluation |
en_US |
dc.title |
Mathematical models of tumor growth with immunotherapy and chemotherapy |
en_US |
dc.type |
Thesis |
en_US |